TORCHLIGHT, NCT04085276: Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment |
|
|
| Active, not recruiting | 3 | 531 | RoW | JS001, Nab-Paclitaxel, Placebo | Shanghai Junshi Bioscience Co., Ltd. | Triple-Negative Breast Cancer | 12/24 | 12/25 | | |
NCT06036563: Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing |
|
|
| Recruiting | N/A | 3200 | RoW | | Air Force Military Medical University, China, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Tang-Du Hospital, The First Affiliated Hospital of Guangzhou Medical University, First Hospital of China Medical University, People's Hospital of Ningxia Hui Autonomous Region, Xinjiang Medical University, Guanxian People's Hospital | Cancer Diagnosis, LungCancer, Gastric Cancer, Liver Cancer, Colorectal Cancer, Esophagus Cancer, Breast Cancer, Pancreas Cancer | 08/25 | 12/25 | | |
NCT04289701: Hypertension Registry of "Hypertension Prevention and Control Initiative in China" |
|
|
| Recruiting | N/A | 200000 | RoW | Health Services for Systematic Hypertension Management | Chinese Academy of Medical Sciences, Fuwai Hospital | Hypertension | 12/22 | 12/24 | | |
